October 17, 2011
– Comments (6)
Anadys Announces Agreement To Be Acquired By Roche
an earlier post on ANDS.
There are currently 32000 ANDS shares in my "fund" (see here) with break-even of around 0.42 USD.
late justification for a little persistence by zzlangerhans and me. maybe my thousand hours biotech study (see here) have been good for something ...
and maybe VRUS should get some more love by the non-portefeuille community ...
but then again ...
The true valuation of Pharmasset stock remains the Schrodinger's cat of baby biotech.
never boring in biopharma equity land ...
this news will help my fund appear a bit more respectable. : )